Loading clinical trials...
Loading clinical trials...
A Multi-center, Investigator-blinded, Randomized Clinical Trial, 18-months, Parallel-group to Compare the Efficacy of Tomeka® Foods Versus Vernonia Amygdalina in the Prevention and Maintenance of Remission of COVID-19 in DRC
Conditions
Interventions
Tomeka®
"Vernonia amygdalina"
Locations
1
Democratic Republic of the Congo
Cliniques Universitaires de Kinshasa
Kinshasa, Democratic Republic of the Congo
Start Date
November 1, 2020
Primary Completion Date
November 1, 2022
Completion Date
December 1, 2022
Last Updated
September 3, 2020
NCT04525716
NCT03188796
NCT06355232
NCT05191420
NCT04611243
NCT04678193
Lead Sponsor
Guyguy K Tshima, MD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions